What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 4 minute read Pharma Industry News Hoth Therapeutics advances HT-001 as promising therapy for EGFR inhibitor-related skin toxicities Hoth Therapeutics, Inc. has announced positive findings for HT-001 treatment, positioning it as a potential breakthrough therapy for… byPallavi MadhirajuMarch 6, 2025